On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance

It is estimated that by the year 2020 there will be approximately 250 million people affected by type 2 diabetes mellitus worldwide (1). Although the primary factors causing this disease are unknown, it is clear that insulin resistance plays a major role in its development. Evidence for this comes from (a) the presence of insulin resistance 10–20 years before the onset of the disease (2, 3); (b) cross-sectional studies demonstrating that insulin resistance is a consistent finding in patients with type 2 diabetes (3–6); and (c) prospective studies demonstrating that insulin resistance is the best predictor of whether or not an individual will later become diabetic (2, 3). Here, I focus on some recent advances in our understanding of human insulin resistance that have been made using nuclear magnetic resonance spectroscopy (NMR). This technique takes advantage of the spin properties of the nuclei of certain isotopes, such as 1H, 13C, and 31P, which endow the isotopes with a magnetic component that can be used to measure the concentration of intracellular metabolites noninvasively and to assess biochemical differences between normal and diabetic subjects. Drawing on NMR studies from my laboratory and others, I first consider the control of glucose phosphorylation and transport in regulating muscle responses to insulin. I then turn to the effects of fatty acids on insulin responses, showing that commonly accepted models that attempt to explain the association of insulin resistance and obesity are incompatible with recent findings. Finally, I propose an alternative model that appears to fit these and other available data.

[1]  L. Mandarino,et al.  Decreased Activation of Skeletal Muscle Glycogen Synthase by Mixed-Meal Ingestion in NIDDM , 1988, Diabetes.

[2]  L. Rossetti,et al.  Mechanisms of fatty acid-induced inhibition of glucose uptake. , 1994, The Journal of clinical investigation.

[3]  R. DeFronzo,et al.  Glucose Toxicity , 1990, Diabetes Care.

[4]  E. Kraegen,et al.  The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. , 1997, Metabolism: clinical and experimental.

[5]  C Cobelli,et al.  Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. , 1996, Diabetes.

[6]  Y. Kruszynska,et al.  Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects. , 1998, Diabetes.

[7]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[8]  L. DiPietro,et al.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.

[9]  G. Dohm,et al.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. , 1988, The Journal of clinical investigation.

[10]  Simon C Watkins,et al.  The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. , 1996, The Journal of clinical investigation.

[11]  Richard Wise,et al.  Science, medicine, and the future , 1998 .

[12]  E. Kraegen,et al.  Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. , 1998, Metabolism: clinical and experimental.

[13]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[14]  S. Lillioja,et al.  Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action , 1997, Diabetes.

[15]  K. Petersen,et al.  13C/31P NMR studies on the mechanism of insulin resistance in obesity. , 1998, Diabetes.

[16]  J. McGarry,et al.  What if Minkowski had been ageusic? An alternative angle on diabetes. , 1992, Science.

[17]  A. Saltiel,et al.  Signaling pathways in insulin action: molecular targets of insulin resistance. , 2000, The Journal of clinical investigation.

[18]  G. Reaven,et al.  Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? , 1976, The American journal of medicine.

[19]  R. Shulman,et al.  Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[21]  R. DeFronzo Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.

[22]  Yii-Der I. Chen,et al.  Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM , 1988, Diabetes.

[23]  R. Bergman,et al.  Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. , 1990, Metabolism: clinical and experimental.

[24]  R. Bergman,et al.  Insulin transport across capillaries is rate limiting for insulin action in dogs. , 1989, The Journal of clinical investigation.

[25]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[26]  G. Shulman,et al.  Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.

[27]  R. DeFronzo The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[28]  E. Kraegen,et al.  A New Antidiabetic Agent, BRL 49653, Reduces Lipid Availability and Improves Insulin Action and Glucoregulation in the Rat , 1994, Diabetes.

[29]  P. Scifo,et al.  Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. , 1999, Diabetes.

[30]  D L Rothman,et al.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.

[31]  B V Howard,et al.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.

[32]  E. Kraegen,et al.  Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. , 1997, Diabetes.

[33]  R. Shulman,et al.  31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[34]  P. J. Randle,et al.  THE GLUCOSE FATTY ACID CYCLE IN OBESITY AND MATURITY ONSET DIABETES MELLITUS , 1965, Annals of the New York Academy of Sciences.

[35]  K. Frayn Insulin resistance and lipid metabolism , 1993 .

[36]  S. Lillioja,et al.  Correlation between muscle glycogen synthase activity and in vivo insulin action in man. , 1984, The Journal of clinical investigation.

[37]  G. Shulman,et al.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. , 2000, The Journal of clinical investigation.

[38]  P. J. Randle,et al.  Regulation of Glucose Uptake by Muscle , 1962 .

[39]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[40]  B. Howard Insulin resistance and lipid metabolism. , 1999, The American journal of cardiology.

[41]  E. Kraegen,et al.  Alterations in the Expression and Cellular Localization of Protein Kinase C Isozymes ε and θ Are Associated With Insulin Resistance in Skeletal Muscle of the High-Fat–Fed Rat , 1997, Diabetes.

[42]  S. O’Rahilly,et al.  Science, medicine, and the future Non-insulin dependent diabetes mellitus: the gathering storm , 1997, BMJ.

[43]  Claudio Cobelli,et al.  Roles of Glucose Transport and Glucose Phosphorylation in Muscle Insulin Resistance of NIDDM , 1996, Diabetes.

[44]  J. Colca,et al.  Reduced Expression of Hexokinase II in Insulin-Resistant Diabetes , 1995, Diabetes.

[45]  G. Shulman,et al.  Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. , 1999, Diabetes.

[46]  E. Newsholme,et al.  Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. , 1964, The Biochemical journal.

[47]  B. Kahn Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. , 1992, The Journal of clinical investigation.

[48]  G. Shulman,et al.  Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. , 1997, Diabetes.